Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
927.3 DKK | +1.13% | -0.16% | +32.83% |
05-31 | Zealand Pharma Secures EU Panel Backing for Severe Hypoglycemia Treatment | MT |
05-30 | Danish Government Implements Stricter Subsidy Rules for Diabetes Drugs | MT |
ETFs positioned on Novo Nordisk A/S
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
21.31% | 200 M€ | +16.70% | ||
10.45% | 5 M€ | +15.85% | ||
5.40% | 17 M€ | +6.09% | - | |
4.67% | 88 M€ | +10.37% | - | |
3.95% | 4 M€ | -.--% | - | |
3.91% | 5 M€ | +10.09% | - | |
3.91% | 14 M€ | +5.66% | - | |
3.78% | 6 M€ | -.--% | ||
3.09% | 12 M€ | +15.09% | - | |
3.02% | 6 M€ | -.--% | - | |
2.87% | 29 M€ | +8.37% | - | |
2.53% | 3,859 M€ | +18.82% | - | |
2.53% | 469 M€ | -2.05% | ||
2.22% | 3 M€ | +9.95% | - | |
1.91% | 2 M€ | -.--% | - | |
1.91% | 2 M€ | +9.19% | - | |
1.67% | 10 M€ | -3.35% | - | |
1.60% | 10 M€ | +6.14% | - | |
1.31% | 253 M€ | +5.88% | ||
1.30% | 48 M€ | +9.22% | ||
1.04% | 276 M€ | +11.40% | - | |
1.03% | 7 M€ | +5.36% | - | |
0.89% | 1,083 M€ | +4.80% | ||
0.79% | 284 M€ | -.--% | ||
0.76% | 786 M€ | -.--% | ||
0.76% | 23 M€ | -.--% | - | |
0.75% | 206 M€ | -.--% | ||
0.70% | 7 M€ | +0.11% | - | |
0.64% | 264 M€ | -.--% | - | |
0.64% | 187 M€ | +9.30% | - | |
0.64% | 477 M€ | +11.68% | ||
0.57% | 727 M€ | +7.40% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.83% | 598B | |
+40.73% | 739B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- NOVO B Stock
- Funds and ETFs Novo Nordisk A/S